"Adaptive Immunity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE).
| Descriptor ID |
D056704
|
| MeSH Number(s) |
G12.450.050
|
| Concept/Terms |
Adaptive Immunity- Adaptive Immunity
- Adoptive Immunity
- Immunity, Adoptive
- Immunity, Adaptive
- Acquired Immunity
- Immunity, Acquired
|
Below are MeSH descriptors whose meaning is more general than "Adaptive Immunity".
Below are MeSH descriptors whose meaning is more specific than "Adaptive Immunity".
This graph shows the total number of publications written about "Adaptive Immunity" by people in this website by year, and whether "Adaptive Immunity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adaptive Immunity" by people in Profiles.
-
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection. PLoS Pathog. 2023 Nov; 19(11):e1011772.
-
A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity. Sci Immunol. 2021 Dec 03; 6(66):eabf1152.
-
COVID-19 antibody testing: From hype to immunological reality. S Afr Med J. 2020 07 27; 110(9):837-841.
-
Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics. Mediators Inflamm. 2012; 2012:584262.